Matches in SemOpenAlex for { <https://semopenalex.org/work/W2302108807> ?p ?o ?g. }
- W2302108807 endingPage "10278" @default.
- W2302108807 startingPage "10269" @default.
- W2302108807 abstract "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an ideal apoptosis inducer and believed to have promise in cancer therapy, yet part of cancer cells exhibit resistance to TRAIL-mediated apoptosis. This necessitates the exploration of agents that resensitizes cancer cells to TRAIL. In our study, we found that Trichostatin A (TSA), an histone deacetylase (HDAC) inhibitor, augmented TRAIL-induced apoptosis in gastric cancer cells in a caspase-dependent manner. Besides, upregulation of DR5 and downregulation of anti-apoptotic proteins including XIAP, Mcl-1, Bcl-2 and Survivin also contributed to this synergism. Noticeably, TSA treatment inhibited Forkhead boxM1 (FOXM1), which expression level showed negative correlation with TRAIL sensitivity. Similarly, silencing of FOXM1 by small interfering RNA (siRNA) resensitized cancer cells to TRAIL and strengthened the TRAIL-augmenting effect of TSA. In addition, we demonstrated the depletion of FOXM1 was a consequence of the inactivation of ERK mediated by TSA. Collectively, it was first shown that TSA potentiated TRAIL sensitivity via ERK/FOXM1 pathway in gastric cancer cells. FOXM1 might serve as a biomarker for predicting sensitivity to TRAIL." @default.
- W2302108807 created "2016-06-24" @default.
- W2302108807 creator A5007931235 @default.
- W2302108807 creator A5019618399 @default.
- W2302108807 creator A5026970877 @default.
- W2302108807 creator A5035260761 @default.
- W2302108807 creator A5048385740 @default.
- W2302108807 creator A5054909215 @default.
- W2302108807 creator A5058965019 @default.
- W2302108807 creator A5079618096 @default.
- W2302108807 creator A5086389738 @default.
- W2302108807 creator A5088615385 @default.
- W2302108807 date "2016-02-01" @default.
- W2302108807 modified "2023-10-17" @default.
- W2302108807 title "Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer" @default.
- W2302108807 cites W1537164477 @default.
- W2302108807 cites W1588994746 @default.
- W2302108807 cites W1970126707 @default.
- W2302108807 cites W1974995883 @default.
- W2302108807 cites W1977162998 @default.
- W2302108807 cites W1977514126 @default.
- W2302108807 cites W1978016743 @default.
- W2302108807 cites W1978747630 @default.
- W2302108807 cites W1984703631 @default.
- W2302108807 cites W1997028722 @default.
- W2302108807 cites W2000095065 @default.
- W2302108807 cites W2001030268 @default.
- W2302108807 cites W2006331115 @default.
- W2302108807 cites W2007718868 @default.
- W2302108807 cites W2009085926 @default.
- W2302108807 cites W2010521473 @default.
- W2302108807 cites W2011326217 @default.
- W2302108807 cites W2014574284 @default.
- W2302108807 cites W2015047229 @default.
- W2302108807 cites W2019494851 @default.
- W2302108807 cites W2025749480 @default.
- W2302108807 cites W2032204792 @default.
- W2302108807 cites W2047972729 @default.
- W2302108807 cites W2048481788 @default.
- W2302108807 cites W2049970280 @default.
- W2302108807 cites W2087057471 @default.
- W2302108807 cites W2115662954 @default.
- W2302108807 cites W2117476538 @default.
- W2302108807 cites W2117692326 @default.
- W2302108807 cites W2124251607 @default.
- W2302108807 cites W2124342958 @default.
- W2302108807 cites W2129305290 @default.
- W2302108807 cites W2156028272 @default.
- W2302108807 cites W2160246583 @default.
- W2302108807 cites W2334948925 @default.
- W2302108807 cites W2411700095 @default.
- W2302108807 cites W2917837889 @default.
- W2302108807 cites W560254554 @default.
- W2302108807 cites W66671524 @default.
- W2302108807 cites W869123678 @default.
- W2302108807 cites W948677531 @default.
- W2302108807 doi "https://doi.org/10.1007/s13277-016-4816-5" @default.
- W2302108807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26831669" @default.
- W2302108807 hasPublicationYear "2016" @default.
- W2302108807 type Work @default.
- W2302108807 sameAs 2302108807 @default.
- W2302108807 citedByCount "14" @default.
- W2302108807 countsByYear W23021088072016 @default.
- W2302108807 countsByYear W23021088072017 @default.
- W2302108807 countsByYear W23021088072018 @default.
- W2302108807 countsByYear W23021088072019 @default.
- W2302108807 countsByYear W23021088072021 @default.
- W2302108807 countsByYear W23021088072022 @default.
- W2302108807 crossrefType "journal-article" @default.
- W2302108807 hasAuthorship W2302108807A5007931235 @default.
- W2302108807 hasAuthorship W2302108807A5019618399 @default.
- W2302108807 hasAuthorship W2302108807A5026970877 @default.
- W2302108807 hasAuthorship W2302108807A5035260761 @default.
- W2302108807 hasAuthorship W2302108807A5048385740 @default.
- W2302108807 hasAuthorship W2302108807A5054909215 @default.
- W2302108807 hasAuthorship W2302108807A5058965019 @default.
- W2302108807 hasAuthorship W2302108807A5079618096 @default.
- W2302108807 hasAuthorship W2302108807A5086389738 @default.
- W2302108807 hasAuthorship W2302108807A5088615385 @default.
- W2302108807 hasConcept C104317684 @default.
- W2302108807 hasConcept C119056186 @default.
- W2302108807 hasConcept C121608353 @default.
- W2302108807 hasConcept C126322002 @default.
- W2302108807 hasConcept C127561419 @default.
- W2302108807 hasConcept C170240278 @default.
- W2302108807 hasConcept C185592680 @default.
- W2302108807 hasConcept C190283241 @default.
- W2302108807 hasConcept C22615655 @default.
- W2302108807 hasConcept C2775975398 @default.
- W2302108807 hasConcept C2776202225 @default.
- W2302108807 hasConcept C2777865847 @default.
- W2302108807 hasConcept C2778305200 @default.
- W2302108807 hasConcept C29537977 @default.
- W2302108807 hasConcept C31573885 @default.
- W2302108807 hasConcept C33195913 @default.
- W2302108807 hasConcept C502942594 @default.
- W2302108807 hasConcept C54009773 @default.
- W2302108807 hasConcept C55493867 @default.